Evidence map›Paper›PMID 25821796›Full record

ArticleBioMed research international2015

Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis patients without cardiovascular risk factors.

Mónica Vázquez-Del Mercado, Lourdes Nuñez-Atahualpa, Mauricio Figueroa-Sánchez, Eduardo Gómez-Bañuelos, Alberto Daniel Rocha-Muñoz, Beatriz Teresita Martín-Márquez, Esther Guadalupe Corona-Sanchez, Erika Aurora Martínez-García, Héctor Macias-Reyes, Laura Gonzalez-Lopez and 4 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03667131 (Effect of Prophylactic Treatment With Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis Patients.), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03667131 phase2completednot on this mapstarted 2017, after this paper: background citation

Effect of Prophylactic Treatment With Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis Patients.

TypeinterventionalSponsorUniversity of GuadalajaraRan2017 to 2018Enrolled59ConditionsRheumatoid ArthritisArmsEnalapril Maleate, Placebo
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Biomarkers of Cardiovascular Stress: A Historical Review.Journal of cardiovascular development and disease · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Mónica Vázquez-Del MercadoInstituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950, Colonia Independencia, 44340 Guadalajara, JAL, Mexico ; Departamento de Reumatología, Hospital Civil "Dr. Juan I. Menchaca", Universidad de Guadalajara, Salvador de Quevedo No. 750, 44100 Guadalajara, JAL, Mexico.
Lourdes Nuñez-AtahualpaHospital Civil de Guadalajara "Fray Antonio Alcalde", Universidad de Guadalajara, Hospital No. 278, 44280 Guadalajara, JAL, Mexico.
Mauricio Figueroa-SánchezHospital Civil de Guadalajara "Fray Antonio Alcalde", Universidad de Guadalajara, Hospital No. 278, 44280 Guadalajara, JAL, Mexico.
Eduardo Gómez-BañuelosInstituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950, Colonia Independencia, 44340 Guadalajara, JAL, Mexico.
Alberto Daniel Rocha-MuñozInstituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950, Colonia Independencia, 44340 Guadalajara, JAL, Mexico.
Beatriz Teresita Martín-MárquezInstituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950, Colonia Independencia, 44340 Guadalajara, JAL, Mexico.
Esther Guadalupe Corona-SanchezInstituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950, Colonia Independencia, 44340 Guadalajara, JAL, Mexico ; Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950, Colonia Independencia, 44340 Guadalajara, JAL, Mexico.ORCID 0000-0002-6540-2444
Erika Aurora Martínez-GarcíaInstituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950, Colonia Independencia, 44340 Guadalajara, JAL, Mexico ; Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950, Colonia Independencia, 44340 Guadalajara, JAL, Mexico.
Héctor Macias-ReyesHospital Civil de Guadalajara "Fray Antonio Alcalde", Universidad de Guadalajara, Hospital No. 278, 44280 Guadalajara, JAL, Mexico.
Laura Gonzalez-LopezDepartamento de Medicina Interna-Reumatología, Hospital General Regional No. 110, Instituto Mexicano del Seguro Social, Circunvalación Oblatos No. 2212, Colonia Oblatos, 44700 Guadalajara, JAL, Mexico.ORCID 0000-0002-6517-6344
Jorge Ivan Gamez-NavaUnidad de Investigacion, Unidad Medica de Alta Especialidad, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Belisario Domínguez No. 1000, Independencia Oriente, 44340 Guadalajara, JAL, Mexico.
Rosa Elena Navarro-HernandezInstituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950, Colonia Independencia, 44340 Guadalajara, JAL, Mexico.
María Alejandra Nuñez-AtahualpaFacultad de Medicina, Universidad Autónoma de Guadalajara, Avenida Patria 1201, Lomas del Valle, 45129 Zapopan, JAL, Mexico.
Javier Andrade-GarduñoFacultad de Medicina, Universidad Autónoma de Guadalajara, Avenida Patria 1201, Lomas del Valle, 45129 Zapopan, JAL, Mexico.
Universidad de Guadalajara · MXMexican Social Security Institute · MXUniversidad Autónoma de Guadalajara · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledThe main cause of death in rheumatoid arthritis (RA) is cardiovascular events. We evaluated the relationship of anticyclic citrullinated peptide (anti-CCP) antibody levels with increased carotid intima-media thickness (cIMT) in RA patients.

methodsForty-five anti-CCP positive and 37 anti-CCP negative RA patients, and 62 healthy controls (HC) were studied. All groups were assessed for atherogenic index of plasma (AIP) and cIMT. Anti-CCP, C-reactive protein (CRP), and levels of tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6) were measured by enzyme-linked immunosorbent assay (ELISA).

resultsThe anti-CCP positive RA patients showed increased cIMT compared to HC and anti-CCP negative (P < 0.001). Anti-CCP positive versus anti-CCP negative RA patients, had increased AIP, TNFα and IL-6 (P < 0.01), and lower levels of high density lipoprotein cholesterol (HDL-c) (P = 0.02). The cIMT correlated with levels of anti-CCP (r = 0.513, P = 0.001), CRP (r = 0.799, P < 0.001), TNFα (r = 0.642, P = 0.001), and IL-6 (r = 0.751, P < 0.001). In multiple regression analysis, cIMT was associated with CRP (P < 0.001) and anti-CCP levels (P = 0.03).

conclusionsLevels of anti-CCP and CRP are associated with increased cIMT and cardiovascular risk supporting a clinical role of the measurement of cIMT in RA in predicting and preventing cardiovascular events.

Indexed as

AdolescentAdultAgedAged, 80 and overArthritis, RheumatoidAtherosclerosisBiomarkersCardiovascular DiseasesCarotid Artery DiseasesCarotid Intima-Media ThicknessCohort StudiesComorbidityC-Reactive ProteinCross-Sectional StudiesFemaleHumansBiomarkersC-Reactive Proteincyclic citrullinated peptideInterleukin-6Peptides, CyclicTumor Necrosis Factor-alpha

Identifiers

PMID25821796
PMCPMC4363501
OpenAlexW1996380610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.